Loading...
Finding new lanes: Chimeric antigen receptor (CAR) T‐cells for myeloid leukemia
BACKGROUND: Myeloid leukemia represents a heterogeneous group of cancers of blood and bone marrow which arise from clonal expansion of hematopoietic myeloid lineage cells. Acute myeloid leukemia (AML) has traditionally been treated with multi‐agent chemotherapy, but conventional therapies have not i...
Saved in:
| Published in: | Cancer Rep (Hoboken) |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
John Wiley and Sons Inc.
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7941581/ https://ncbi.nlm.nih.gov/pubmed/32671999 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cnr2.1222 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|